Lavo Life Sciences went through Y Combinator in the Winter 2023 batch, describing itself as AI for drug formulation. Y Combinator's company directory lists it as Inactive. The directory does not say why a company stopped, and this page does not guess.
- Batch
- Winter 2023
- What they did
- AI for drug formulation
- Industry
- Healthcare
- Team size
- 3
- Status
- Inactive, as listed by Y Combinator
Its batch
Winter 2023 had 274 companies in YC's listing: 201 Active, 34 Acquired, 0 Public and 39 Inactive, so Lavo Life Sciences is one of 39 companies from that batch listed as Inactive (14%). Across YC batches at least two years old, 23% of companies are listed Inactive.
Statuses are Y Combinator's own listing in its public company directory, read on the date shown. YC's directory can drop companies altogether, so the Inactive counts here are a floor, not a full count of companies that stopped. Acquired and Public are as YC lists them; neither says anything about the price or the outcome for founders.
The record: Lavo Life Sciences in the Y Combinator directory. Measured 2026-09-26 from Y Combinator's company directory.
YC Winter 2023All shut-down YC companiesYC outcomes
Tools for this story
Each opens in a new tab, filled in for Lavo Life Sciences. With no account yet, you sign up free and land on the result.